FACBC

DRUG6 trials

Sponsors

David M. Schuster, MD, Emory University

Conditions

Breast CancerCancers of the Head and NeckParathyroid DiseaseProstate CancerRecurrent Prostate Cancer

Early Phase 1

Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast

CompletedNCT01659645

Emory UniversityBreast Cancer

Start: 2012-08-31End: 2015-01-31Updated: 2016-10-27

FACBC for Head and Neck Cancers

WithdrawnNCT01933269

Emory UniversityCancers of the Head and Neck

Start: 2015-05-31End: 2018-02-01Updated: 2018-02-05

Phase 2

FACBC PET/CT for Recurrent Prostate Cancer

CompletedNCT00562315

David M. Schuster, MDProstate Cancer

Start: 2007-10-31End: 2015-07-31Updated: 2016-06-21

FACBC Outcomes for Post Prostatectomy

CompletedNCT01666808

Emory UniversityProstate Cancer

Start: 2012-09-30End: 2022-04-18Updated: 2023-08-02

FACBC for Recurrent Prostate Cancer

CompletedNCT01808222

David M. Schuster, MDRecurrent Prostate Cancer

Start: 2013-11-30End: 2017-09-13Updated: 2019-01-07

Unknown Phase

Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas

CompletedNCT01574287

David M. Schuster, MDParathyroid Disease

Start: 2012-08-31End: 2019-05-15Updated: 2019-07-02

Related Papers

<sup>18</sup>F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.

2021-05-07121 citations